Hostname: page-component-745bb68f8f-5r2nc Total loading time: 0 Render date: 2025-01-24T23:17:49.238Z Has data issue: false hasContentIssue false
  • English
  • Français

Differential Diagnosis of Parkinsonism

Published online by Cambridge University Press:  02 December 2014

A. Jon Stoessl  and
Jean Rivest
A. Jon Stoessl
Affiliation:
The Neurodegenerative Disorders Centre, Vancouver Hospital & Health Sciences Centre, Vancouver
Jean Rivest
Affiliation:
Dept. of Neurology, C.H.U. Sherbrooke
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The diagnosis of Parkinson's disease is predominantly clinical, based on a combination of the cardinal features of tremor, bradykinesia and rigidity. The differential essentially lies between other conditions resulting in tremor, of which essential tremor is the commonest, and other akinetic-rigid syndromes. These include progressive supranuclear palsy, multiple system atrophy, toxins and other degenerative disorders, including diffuse Lewy body disease and corticobasal degeneration. The key clinical features of these disorders and a practical diagnostic approach are briefly reviewed in this article.

Résumé

RÉSUMÉ

Le diagnostic de la maladie de Parkinson est avant tout clinique et basé sur une combinaison de manifestations dont le tremblement, la bradykinésie et la rigidité. Le diagnostic différentiel regroupe d'autres entités comportant du tremblement, dont le tremblement essentiel est la plus fréquente, et d'autres syndromes akinéto-rigides. Parmices derniers, mentionnons la paralysie supranucléaire progressive, l'a-trophie multisystémique, les toxines et les autres maladies dégénératives, incluant la maladie diffuse à corps de Lewy et la dégénérescence corticobasale. Nous revoyons dans cet article les principales manifestations cliniques de ces maladies et nous proposons une approche diagnostique pratique.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 26 , Issue S2 , August 1999 , pp. S1 - S4
Copyright
Copyright © The Canadian Journal of Neurological 1999

References

1. Barclay, CL, Lang, AE. Dystonia in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1997; 62: 352–356.Google Scholar
2. Dubinsky, RM, Jankovic, J. Progressive supranuclear palsy and a mult-infarct state. Neurology 1987; 37: 570–576.Google Scholar
3. Litvan, I, Agid, Y, Calne, D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1–9.Google Scholar
4. Fearnley, JM, Lees, AJ. Striatonigral degeneration. A clinicopathological study. Brain 1990; 113: 1823–1842.CrossRefGoogle ScholarPubMed
5. Wenning, GK, Tison, F, Ben Shlomo, Y, Daniel, SE, Quinn, NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997; 12: 133–147.CrossRefGoogle ScholarPubMed
6. Savoiardo, M, Girotti, F, Strada, L, Ciceri, E. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm (Suppl) 1994; 42: 93–110.Google Scholar
7. Rosenberg, RN, Fowler, HL. Autosomal dominant motor system disorder of the Portuguese. A review. Neurology 1981; 31: 1124–1126.Google Scholar
8. Kawaguchi, Y, Okamoto, T, Taniwaki, M, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genetics 1994; 8: 221–228.Google Scholar
9. Koeppen, AH. The hereditary ataxias. J Neuropathol Exp Neurol 1998; 57: 531–543.CrossRefGoogle ScholarPubMed
10. Fitzgerald, PM, Jankovic, J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord 1989; 4: 249–260.CrossRefGoogle ScholarPubMed
11. Micheli, F, Pardal, MF, Gatto, M, et al. Flunarizine- and cinnarizine-induced extrapyramidal reactions. Neurology 1987; 37: 881–884.CrossRefGoogle ScholarPubMed
12. Negrotti, A, Calzetti, S. A long-term follow-up study of cinnarizine-and flunarizine-induced parkinsonism. Mov Disord 1997; 12: 107–110.CrossRefGoogle ScholarPubMed
13. Nath, A, Hobson, DE, Russell, A. Movement disorders with cerebral toxoplasmosis and AIDS. Mov Disord 1993; 8: 107–112.Google Scholar
14. Factor, SA, Podskalny, GD, Barron, KD. Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clin-ico-pathological case report. J Neurol Sci 1994; 127: 114–120.Google Scholar
15. Calne, DB, Chu, NS, Huang, CC, Lu, CS, Olanow, W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 1994; 44: 1583–1586.Google Scholar
16. Uitti, RJ, Snow, BJ, Shinotoh, H, et al. Parkinsonism induced by solvent abuse. Ann Neurol 1994; 35: 616–619.Google Scholar
17. Tanner, CM. Occupational and environmental causes of parkinsonism. Occup Med 1992; 7: 505–513.Google Scholar
18. Burkhardt, CR, Filley, CM, Kleinschmidt-DeMasters, BK, de la Monte, S, Norenberg, MD, Schneck, SA. Diffuse Lewy body disease and progressive dementia. Neurology 1988; 38: 1520–1528.Google Scholar
19. Perry, RH, Irbing, D, Blessed, G, Fairbairn, A, Perry, EK. Senile dementia of Lewy body type. A clinically and neuropathological-ly distinct form of Lewy body disease in the elderly. J Neurol Sci 1990; 95: 119–139.Google Scholar
20. Gibb, WRG, Luther, PJ, Marsden, CD. Corticobasal degeneration. Brain 1989; 112: 1171–1192.Google Scholar
21. Riley, DE, Lang, AE, Lewis, A, et al. Cortical-basal ganglionic degeneration. Neurology 1990; 40: 1203–1212.Google Scholar
22. Litvan, I, Agid, Y, Goetz, C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997; 48: 119–125.CrossRefGoogle ScholarPubMed
23. Wenning, GK, Litvan, I, Jankovic, J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998; 64: 184–189.CrossRefGoogle ScholarPubMed
24. Nagahama, Y, Fukuyama, H, Turjanski, N, et al. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls. Mov Disord 1997; 12: 691–696.CrossRefGoogle ScholarPubMed
25. Feany, MB, Mattiace, LA, Dickson, DW. Neuropathologic overlap of progressive supranuclear palsy, Pick’s disease and corticobasal degeneration. J Neuropathol Exp Neurol 1996; 55: 53–67.Google Scholar
26. Kertesz, A. Frontotemporal dementia, Pick disease, and corticobasal degeneration. One entity or 3? 1. Arch Neurol 1997; 54: 1427–1429.Google Scholar
27. Lin, SK, Lu, CS, Vingerhoets, FJG, et al. Isolated involvement of substantia nigra in acute transient Parkinsonism: MRI and PET observations. Parkinsonism Rel Disord 1995; 1: 67–73.Google Scholar
28. Rajput, AH, Rozdilsky, B, Rajput, A. Accuracy of clinical diagnosis in Parkinsonism-a prospective study. Can J Neurol Sci 1991; 18: 275–278 CrossRefGoogle ScholarPubMed
29. Hughes, AJ, Daniel, SE, Kilford, L, Lees, AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181–184.Google Scholar
30. Rajput, AH, Rozdilsky, B, Rajput, A, Ang, L. Levodopa efficacy and pathological basis of Parkinson syndrome. Clin Neuropharmacol 1990; 13: 553–558.Google Scholar